New insights into the metabolic and molecular basis for diabetic neuropathy.
about
Gender differences in nerve regeneration after sciatic nerve injury and repair in healthy and in type 2 diabetic Goto-Kakizaki ratsHigh glucose stimulates TNFα and MCP-1 expression in rat microglia via ROS and NF-κB pathways.Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions.Global transcriptional programs in peripheral nerve endoneurium and DRG are resistant to the onset of type 1 diabetic neuropathy in Ins2 mice.Increased peripherin in sympathetic axons innervating plantar metatarsal arteries in STZ-induced type I diabetic rats.Low-Dose Pulsatile Interleukin-6 As a Treatment Option for Diabetic Peripheral NeuropathyBurning through the pain: treatments for diabetic neuropathy.Age-dependent slowing of enteric axonal transport in insulin-resistant mice.Diabetes-related microvascular and macrovascular diseases in the physical therapy settingInsulin receptor substrate 2 expression and involvement in neuronal insulin resistance in diabetic neuropathyThe BBZDR/Wor rat model for investigating the complications of type 2 diabetes mellitus.Effect of Chinese herbal compound Naofucong () on the inflammatory process induced by high glucose in BV-2 cells.Nerve growth factor: from the early discoveries to the potential clinical useCoenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db-/db- mouse, a type 2 diabetes modelAge-related obesity and type 2 diabetes dysregulate neuronal associated genes and proteins in humans.Diabetic neuropathy differs in type 1 and type 2 diabetes.Phosphatidic acid mediates demyelination in Lpin1 mutant mice.Increased nerve growth factor signaling in sensory neurons of early diabetic rats is corrected by electroacupuncture.Effect of C-peptide on diabetic neuropathy in patients with type 1 diabetesThe effects of C-peptide on type 1 diabetic polyneuropathies and encephalopathy in the BB/Wor-rat.Oxidative stress and dysregulation of the taurine transporter in high-glucose-exposed human Schwann cells: implications for pathogenesis of diabetic neuropathyMotor unit number estimate as a predictor of motor dysfunction in an animal model of type 1 diabetes.The beneficial effects of C-Peptide on diabetic polyneuropathy.C-peptide and long-term complications of diabetes.Emerging therapy for diabetic neuropathy: cell therapy targeting vessels and nerves.APOE gene polymorphisms and diabetic peripheral neuropathy.Oxidative, metabolic, and apoptotic responses of Schwann cells to high glucose levels.Pharmacological evaluation of rat dorsal root ganglion neurons as an in vitro model for diabetic neuropathy.Glycolytic metabolite methylglyoxal inhibits cold and menthol activation of the transient receptor potential melastatin type 8 channel.Dynamic changes of neuroskeletal proteins in DRGs underlie impaired axonal maturation and progressive axonal degeneration in type 1 diabetes.Protective effect of Jiaweibugan decoction against diabetic peripheral neuropathy.Will C-peptide substitution make a difference in combating complications in insulin-deficient diabetes?Diabetic neuropathy: electrophysiological and morphological study of peripheral nerve degeneration and regeneration in transgenic mice that express IFNbeta in beta cells.Interleukin-6 attenuates the development of experimental diabetes-related neuropathy.Nociceptive Alteration by High Sucrose Diet in Hypoestrogenic Wistar Rats.
P2860
Q28655616-D85262F4-9419-46AA-B075-1433C4BFB9E5Q33565706-E69C47FD-33AE-434D-A4F7-2D7EEE3802A7Q33583006-A0B3354B-E174-46DC-A8E2-BC7B949EC088Q33593046-0B4F9DCE-1FE4-43A0-935B-62D58C14DC75Q33606000-16A93509-94DA-4E47-AD0D-FB3817F6A72EQ33621822-AE0D205E-E889-4E47-A573-8E0D06A0D6DCQ34485306-620D96A9-26BE-43DF-8DA2-3A2F9A6AB3B8Q34574725-5EA608D3-B942-469C-9B7B-7C56BF576C77Q34830905-5D6440AE-2CD0-4438-970A-FF5C9EDCF4E2Q35095336-B5EC9424-2448-4A6F-9222-33958FFF63D7Q35823982-A4CFE942-12D5-48F4-AE0B-D3418FE6BD75Q36029585-9E713803-E2E5-4421-B319-0BED4DE9349DQ36526946-2CC1B18E-E756-4D07-9FE1-38B0144BE608Q36535440-5DE46001-5303-4FC6-A254-95F81B546E46Q36557442-88971E33-3627-4F88-B37F-BE0CBDED670EQ36675877-383154CB-CBEE-43D9-9060-7378E63B3D16Q36720957-366846D6-236F-48BB-A77F-C8789B5F232BQ36844962-AF71CFAD-D816-4B5A-99A0-3A418356616EQ37113466-B71CD8BF-E373-4E0D-82E1-36D30A89E8DAQ37147785-8516F4F3-DC2A-4E49-BACB-29E38212F083Q37325187-F47AE4D4-3990-4735-85DB-87514A5EE775Q37337292-C2CDF998-122A-4056-9ACC-90BBE46F0C13Q37663812-07F5265E-F93D-482F-8795-F0258AE86D44Q37815562-27C98906-5F72-4C97-9984-CD72DFFC24C5Q37974944-77062394-D794-494D-877F-CCC8ED56B5B9Q38051335-2E0A41D2-0C9B-4FB7-9918-3CF8F65F1ADEQ38909374-C43EF59C-C4FE-44F3-A84E-6A625BB6C9EAQ39544960-919E38D4-C3A6-4D46-89AF-6F6043086B71Q40250061-062692B4-E639-432D-A24D-21C7D99FD385Q41945335-F2D5C97E-402C-438A-9DAB-B49A39AF97E8Q42844482-2738F647-8AA9-44D0-ADBC-073B6A0537C2Q42976555-8FC8CE81-93B8-4BBC-A19C-58BFE915A9D7Q43240737-7074BDC4-E9F2-417E-A0AD-27C80DF02C17Q46978757-32672E0B-3A21-46B9-8ADE-27212EA06497Q53056509-93426652-222B-4BA7-A4CA-E663F635128D
P2860
New insights into the metabolic and molecular basis for diabetic neuropathy.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
New insights into the metabolic and molecular basis for diabetic neuropathy.
@ast
New insights into the metabolic and molecular basis for diabetic neuropathy.
@en
type
label
New insights into the metabolic and molecular basis for diabetic neuropathy.
@ast
New insights into the metabolic and molecular basis for diabetic neuropathy.
@en
prefLabel
New insights into the metabolic and molecular basis for diabetic neuropathy.
@ast
New insights into the metabolic and molecular basis for diabetic neuropathy.
@en
P1476
New insights into the metabolic and molecular basis for diabetic neuropathy.
@en
P2093
P2888
P304
P356
10.1007/S00018-003-3084-X
P577
2003-11-01T00:00:00Z